BCS Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-486
Closed -$282K 338
2025
Q4
$282K Buy
+486
New +$275K 0.03% 303
2025
Q1
Sell
-419
Closed -$218K 260
2024
Q4
$218K Buy
+419
New +$230K 0.05% 238

Other funds holding TMO

BCS Wealth Management's TMO Position: Q1 2026 in Review

BCS Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 486 shares — an estimated $282K sold.

BCS Wealth Management first reported a position in TMO in Q4 2024 and held it in 2 quarters. The position peaked at $282K in Q4 2025. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • BCS Wealth Management reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • BCS Wealth Management sold 486 Thermo Fisher Scientific shares in Q1 2026, an estimated $282K.
  • BCS Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2024 and held it in 2 quarters.
  • BCS Wealth Management's Thermo Fisher Scientific position peaked at $282K in Q4 2025.
  • 2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on BCS Wealth Management's 13F filing for Q1 2026, filed 17 Apr 2026.